Invest Different
Results 1 - 10 of 61 : 1 2 3 4 5 6 7 Next
Do the possible benefits outweigh the risks?
Let's look at this year's prospects for this company.
This mechanical strategy could be magic.
Geron's Hurry-Up-and-Wait Strategy
Clinical trials started, now the waiting begins.
If You Can't Beat 'Em, Join 'Em: Amgen Goes Generic
Biosimilars are coming -- might as well get a piece of the action.
What's Up With the Back-Slapping, Sequenom?
Some sales numbers would be nice.
Has Geron Become the Perfect Stock?
Finding companies that have all the right stuff can produce winners.
In Drug Development, Help Is Crucial
Curis gets some from the The Leukemia & Lymphoma Society.
Breaking Down a Biotech Press Release
Sometimes you have to take a deep dive.
Whoa! My Stock Just Crushed the Market!
These stocks just took off, but are they about to make a return trip to Earth?
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK